Recent studies indicate that hyperbaric oxygen therapy (HBOT), a well-established therapy for decompression illness, could be a potential therapy for Alzheimer’s disease (AD). However, due to oxygen toxicity i.e., increased oxidative stress implicated in HBOT, the risk and benefit of HBOT for AD patients need to be further assessed clinically.

Huang (2018). Hyperbaric Oxygen Therapy for Alzheimer’s Disease. EC pharmacology and toxicology, 2018 Mar;6(3):74-75. https://www.ncbi.nlm.nih.gov/pubmed/30215058